TODAY

2024. 07. 27.

D-40

Key Speakers

  • Presidential Lecture

    11:00-11:40, Sep. 7 (Sat)

    Obesity and Fatty Liver
    : Common but Ignored

    Cheol-Young Park

    Sungkyunkwan University
    (Korea)
  • EASO Presidential Lecture

    18:05-18:40, Sep. 6 (Fri)

    Management of Obesity in Older Adults

    Volkan Yumuk

    Istanbul University-Cerrahpaşa
    (Turkey)
  • Plenary Lecture 1

    11:10-11:50, Sep. 6 (Fri)

    GLP-1 Based Therapy of obesity

    Michael A. Nauck

    Ruhr-University Bochum
    (Germany)
  • Plenary Lecture 2

    15:40-16:20, Sep. 6 (Fri)

    Management of Youth Type 2 Diabetes: New Pharmacotherapeutic Modalities

    Silva Arslanian

    University of Pittsburgh
    (USA)
  • Plenary Lecture 3

    13:50-14:30, Sep. 7 (Sat)

    How Muscle Mass and Metabolism Affects Energy Metabolism and Functional Capacity

    William Evans

    University of California, Berkeley
    (USA)
  • Plenary Lecture 4

    17:00-17:40, Sep. 7 (Sat)

    Semaglutide, a Second-Generation Obesity Medication for the Treatment and Prevention of Cardiometabolic Disease

    W. Timothy Garvey

    University of Alabama at Birmingham
    (USA)
  • Keynote Lecture 1

    08:30-09:10, Sep. 6 (Fri)

    SF-1 Targets in the Hypothalamus: Novel Pathways Regulating Energy Balance and Metabolism

    Joel K. Elmquist

    UT Southwestern Medical Center
    (USA)
  • Keynote Lecture 2

    08:30-09:10, Sep. 7 (Sat)

    Cardiometabolic Health: Importance of Lifestyle Vital Signs

    Jean-Pierre Després

    VITAM – Research Centre on Sustainable Health
    (Canada)
  • Keynote Lecture 3

    14:30-15:10,Sep. 7 (Sat)

    Human Adipose Tissue Metabolism: What Happens with Obesity

    Michael D. Jensen

    Mayo College of Medicine
    (USA)
  • Special Scientific Session 1

    13:00-14:00, Sep. 6 (Fri)

    Nutrients-Stimulated Hormone-Based Pharmacotherapy for the Treatment of Obesity: Sparks from the Pipeline!

    Ania Jastreboff

    Yale University
    (USA)
  • Special Scientific Session 2

    12:50-13:50, Sep. 7 (Sat)

    Clinical Implication of GLP-1 Receptor Agonists and SGLT2 Inhibitors from a Cardiometabolic Perspective

    Soo Lim

    Seoul National University
    (Korea)